Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : VALENCE TECHNOLOGY (VLNC) -- Ignore unavailable to you. Want to Upgrade?

To: FMK who wrote (10708)	4/25/1999 1:11:00 PM
From: Larry Brubaker	Read Replies (1) \| Respond to of 27311

FMK, so you are saying it is another fabrication of one of your inside sources? I'm not surprised you value the opinion of "midwestpatents" so highly. He provides absolutely no substantiation for his pronouncements. One must simply chose to have faith that midwestpatents is indeed what he represents himself to be and knows what he claims to know. Maybe, just maybe, midwestpatents is another incarnation of yourself, ala FMKX, Dr. Procrustes, Quashimoto,....?

To: FMK who wrote (10708)	4/25/1999 1:26:00 PM
From: Dennis V.	Read Replies (1) \| Respond to of 27311

Fred, WAG; It looks like Lev thinks the phosphate patent is worth about $18,000,000 in earnings per year over the next 1-2 yrs. Let me explain. A doubling of the stock price would amount to roughly 180,000,000 additional capitalization. At a PE of 20, this amounts to approx. $9,000,000 in earnings. The market is forward looking but would also discount this figure in valuing the stock. Anticipating a 50% discount, Lev could be estimating about $18,000,000 in earnings or $.60 per share. This will not sink in until there is a PO and analysts start following the stock. Outyears are anyone's guess, could be substantial.